Determination of genetic toxicity and potential carcinogenicity in vitro - Challenges post the Seventh Amendment to the European Cosmetics Directive

Mutagenesis

Volumn 22, Issue 1, 2007, Pages 5-13

  Tweats, D J ^a   Scott, A D ^b   Westmoreland, C ^b   Carmichael, P L ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COSMETIC; REACTIVE OXYGEN METABOLITE;

ANIMAL TESTING ALTERNATIVE; BONE MARROW; CARCINOGENESIS; CARCINOGENICITY; CELL ASSAY; CELL LINE; CELLULAR IMMUNITY; CHEMICAL ANALYSIS; COMPUTER ANALYSIS; COSMETIC INDUSTRY; CYTOTOXICITY TEST; EPIGENETICS; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDUCED MUTATION; LAW; MARKETING; METABOLIC ACTIVATION; METABOLOMICS; MICRONUCLEUS TEST; NONHUMAN; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PROTEOMICS; REDUCTION; REVIEW; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; TRANSCRIPTOMICS; VALIDATION PROCESS;

ANIMAL EXPERIMENTATION; ANIMAL TESTING ALTERNATIVES; ANIMALS; CARCINOGENICITY TESTS; COSMETICS; DERMATOLOGIC AGENTS; DRUG EVALUATION, PRECLINICAL; EUROPE; HUMANS; MUTAGENICITY TESTS;

ANIMALIA;

EID: 33846071711     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gel052     Document Type: Review

References (53)

1. Kirkland,D., Aardema,M., Henderson,L. and Müller,L. (2005) Evaluation of the ability of a battery of 3 in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256.
2. Matthews,E.J., Kruhlak,N.L., Cimino,M.C., Benz,R.D. and Contrera,J.F. (2006) An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol., 44, 83-96.
3. Tweats,D.J., Blakey,D., Heflich,R.H., Jacobs,A., Jacobsen,S.D., Morita,T., Nohmi,T., O'Donovan,M.R., Sasaki,Y.F., Sofuni,T. and Tice,R. (2006) Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. II. Identification of 'in vivo only' positive compounds in the bone marrow micronucleus test. Mutat. Res., (in press).
4. Pastoor,T. and Stevens,J. (2005) Historical perspective of the cancer bioassay. Scand. J. Work Environ. Health, 31, 119-122.
5. Kirkland,D., Pfuhler,S. and Tweats,D et al. (2006) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat. Res., (in press).
6. Halliwell,B. (2003) Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett., 540, 3-6.
7. Wee,L.M., Long,L.H., Whitemen,M. and Halliwell,B. (2003) Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's modified Eagles medium. Free Radic. Res., 37, 1123-1130.
8. Tweats,D.J. (1992) Cell culture and mutagenicity assessment. Analyt. Proc., 29, 476-481.
9. Sofuni,T., Matsuoka,A., Sawada,M., Ishidate,M.,Jr, Zeiger,E. and Shelby,M.D. (1990) A comparison of chromosome aberration induction by 25 compounds tested by two Chinese hamster cell (CHL and CHO) systems in culture. Mutat. Res., 241, 175-213.
10. Oka,H., Ikeda,K., Yoshimura,H., Ohuchida,A. and Honma,M. (2006) Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines. Mutat. Res., 606, 52-60.
11. Chaung,W., Mi,L.-J. and Boorstein,R.J. (1997) The p53 status of Chinese hamster V79 cells frequently used for studies of DNA damage and DNA repair. Nucleic Acid Res., 25, 992-994.
12. Kirkland,D. (1992) Chromosomal aberration tests in vitro: problems with protocol design and interpretation of results. Mutagenesis, 7, 95-106.
13. Scott,D., Galloway,S.M., Marshall,R.,Jr, Ishidate,M.,Jr, Brusick,D., Ashby,J. and Myhr,B.C. (1991) Genotoxicity under extreme culture conditions. A report from ICPEMC Task group 9. Mutat. Res., 257, 147-204.
14. Greenwood,S.K., Hill,R.B., Sun,J.T., Armstrong,M.J., Johnson,T.E., Gara,J.P. and Galloway,S.M. (2004) Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Environ. Mol. Mutagen., 43, 36-44.
15. Rodriguez-Antona,C., Donato,M.T., Boobis,A., Edwards,R.J., Watts,P.S., Castell,J.V. and Gomez-Lechon,M.J. (2002) Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica, 32, 505-520.
16. Crespi,C.L., Gonzalez,F.J., Steimel,D.T., Turner,T.R., Gelboin,H.V., Penman,B.W. and Langenbach,R. (1991) A metabolically competent human cell line expressing 5 cDNAs encoding procarcinogen-activating enzymes: Application to mutagenicity testing. Chem. Res. Toxicol., 4, 566-572.
17. Doherty,A.T., Ellard,S., Parry,E.M. and Parry,J.M. (1996) An investigationinto the activation and deactivation of chlorinated hydrocarbons to genotoxins in metabolically competent human cells. Mutagenesis, 11, 247-274.
18. Johnson,D.E. and Rodgers,A.D. (2006) Computational toxicology: heading toward more relevance in drug discovery and development. Curr. Opin. Drug Discov. Dev., 9, 29-37.
19. Hastwell,P.W., Chai,L.L., Roberts,K.J., Webster,T.W., Harvey,J.S., Rees,R.W. and Walmsley,R.M. (2006) High-specificity and highsensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat. Res., 607, 160-175.
20. Leccia,M.T., Richard,M.J., Joanny-Crisci,F. and Beani,J.C. (1998) UV-A1 cytotoxicity and antioxidant defence in keratinocytes and fibroblasts. Eur. J. Dermatol., 8, 478-482.
21. Maskell,S.,Malcomber,S.,Windebank,S., Carmichael,P. and Scott,A. (2006) Development of a human keratinocyte cell line that is up-regulated for the expression of superoxide dismutase 1 (SOD1). Toxicology, (in press).
22. Coecke,S., Ahr,H. and Blaauboer,B.J. et al. (2006) Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern Lab Anim., 34, 49-84.
23. Glatt,H., Schneider,H. and Liu,Y. (2005) V79-hCYP2E1-hSULT1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals. Mutat. Res., 580, 41-52.
24. Knasmuller,S., Mersch-Sundermann,V., Kevekordes,S., Darroudi,F., Huber,W.W., Hoelzl,C., Bichler,J. and Majer,B.J. (2004) Use of humanderived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology, 198, 315-328.
25. Aninat,C., Piton,A., Glaise,D., Le Charpentier,T., Langouet,S., Morel,F., Guguen-Guillouzo,C. and Guillouzo,A. (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab. Dispos., 34, 75-83.
26. Marek,C.J., Cameron,G.A., Elrick,L.J., Hawksworth,G.M. and Wright,M.C. (2003) Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro. Biochem. J., 370, 763-769.
27. Burke,Z.D., Shen,C.N., Ralphs,K.L. and Tosh,D. (2006) Characterization of liver function in transdifferentiated hepatocytes. J. Cell. Physiol., 206, 147-159.
28. Aubrecht,J. and Caba,E. (2005) Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity. Pharmacogenomics, 6, 419-428.
29. Gasch,A.P., Spellman,P.T., Kao,C.M., Carmel-Harel,O., Eisen,M.B., Storz,G., Botstein,D. and Brown,P.O. (2000) Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell, 11, 4241-4257.
30. Jelinsky,S .A. and Samson,L.D. (1999) Global response of Saccharomyces cerevisiae to an alkylating agent. Proc. Natl Acad. Sci. USA, 96, 1486-1491.
31. Jelinsky,S.A., Estep,P., Church,G.M. and Samson,L.A. (2000) Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol. Cell. Biol., 20, 8157-8167.
32. Amundson,S.A., Do,K.T., Vinikoor,L., Koch-Paiz,C.A., Bittner,M.L., Trent,J.M., Meltzer,P. and Fornace,A.J.,Jr (2005) Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene., 24, 4572-4579.
33. Newton,R.K., Aardema,M. and Aubrecht,J. (2004) The utility of DNA microarrays for characterizing genotoxicity. Environ. Health Perspect., 112, 420-422.
34. Jiang,P., Gan,M., Huang,H., Shen,X., Wang,S. and Yao,K. (2005) Proteome analysis of antiproliferative mechanism of 12-O-tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells. J. Proteome Res., 4, 599-605.
35. Mauthe,M.J., Gibson,D.P., Bunch,R.T. and Custer,L. (2001) The Syrian hamster embryo (SHE) cell transformation assay; a review of the methods and results. Toxicol. Pathol., 29 (Suppl.), 138-146.
36. German,M.J., Hammiche,A. and Ragavan,N. et al. (2006) Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophys. J., 90, 1-13.
37. Walsh,M.J., German,M.J., Singh,M., Pollock,H.M., Hammiche,A, Kyrgiou,M., Stringfellow,H.F., Paraskevadis,E., Martin-Hirsch,P.L. and Martin,F.L. (2006) IR microspectroscopy: potential applications in cervical cancer screening. Cancer Lett., [Epub ahead of print].
38. Ippolito,J.E., Xu,J., Jain,S., Moulder,K., Mennerick,S., Crowley,J.R., Townsend,R.R. and Gordon,J.I. (2005) An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc. Natl Acad. Sci. USA, 102, 9901-9906.
39. Maurici,D., Aardema,M. and Corvi,R. et al. (2005) Genotoxicity and mutagenicity. Altern. Lab. Anim., 33 (Suppl. 1), 117-130.
40. Curren,R.D., Mun,G.C., Gibson,D.P. and Aardema,M.J. (2006) Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm™). Mutat. Res., 607, 192-204.
41. Flamand,N., Marrot,L., Belaidi,J.P., Bourouf,L., Dourille,E., Feltes,M. and Meunier,J.R. (2006) Development of genotoxicity test procedures with Episkin®, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? Mutat. Res., 606, 39-51.
42. Xu,J., Ma,M. and Purcell,W.M. (2003) Biochemical and functional changes of rat liver spheroids during spheroid formation and maintenance in culture: II. nitric oxide synthesis and related changes. J. Cell. Biochem., 90, 1176-1185.
43. Dal Negro,G., Vandin,L., Bonato,M. and Sciuscio,D. (2006) Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system. Toxicol. In Vitro, 20, 743-749.
44. Jones,P.A. and Baylin,P.A. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
45. Vuillemenot,B.R., Hutt,J.A. and Belinsky,S.A. (2006) Gene promoter hypermethylation in mouse lung tumours. Mol.Cancer Res., 4, 267-273.
46. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
47. Bocchetta,M. and Carbone,M. (2004) Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation. Oncogene, 23, 6484-6491.
48. Clarke,M.F. and Becker,M.F. (2006) Stem cells:the real culprits in cancer? Sci. Amer., 295, 52-59.
49. Trosko,J.E., Chang,C.C., Upham,B.L. and Tai Mh,H. (2004) Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication. Ann. NY Acad. Sci., 1028, 192-201.
50. Trosko,J.E. and Upham,B.L. (2005) The emperor wears no clothes in the field of carcinogen risk assessment. Mutagenesis, 20, 81-97.
51. Begley,T.J., Rosenbach,A.S., Ideker,T. and Samson,L.D. (2002) Damage recovery pathways in Saccaromyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol. Cancer Res., 1, 103-112.
52. Ideker,T., Ozier,O., Schwikowski,B. and Siegel,A. (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics, 18, 233-240.
53. Christopher,R., Dhiman,A., Fox,J., Gendelmann,R., Haberitcher,T., Kagle,D., Spizz,G., Khalil,I.G. and Hill,C. (2004) Data-driven computer simulation of human cancer cell. Ann. NY Acad. Sci., 120, 132-153.